e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Chemical exposures and respiratory effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Concentration profile of persistent organic pollutants (POPs) in blood serum of patients with COPD
M. E. Cioroiu, D. Tarcau, B. Cioroiu, R. Mocanu (Iasi, Romania)
Source:
Annual Congress 2010 - Chemical exposures and respiratory effects
Session:
Chemical exposures and respiratory effects
Session type:
Thematic Poster Session
Number:
1484
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. E. Cioroiu, D. Tarcau, B. Cioroiu, R. Mocanu (Iasi, Romania). Concentration profile of persistent organic pollutants (POPs) in blood serum of patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 1484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Exposure to PM2.5 and PM2.5-bound PAHs and its influence on respiratory tract function and cytokines concentrations changes in healthy adults.
Source: Virtual Congress 2020 – Air pollution as a cause of respiratory disease
Year: 2020
Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
Presence of volatile organic compounds (VOC) in exhaled breath in patients diagnosed with lung cancer (LC) vs healthy patients. Preliminary data
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Airways changes related to air pollution exposure in wheezing children
Source: Eur Respir J 2012; 39: 246-253
Year: 2012
Impact of air pollutant of polycyclic aromatic hydrocarbons (PAHs) on the yearly decline of pulmonary in patients with asthma
Source: Virtual Congress 2020 – Air pollution considerations
Year: 2020
Peptide LL-37 levels in sputum in COPD farmers after exposure to organic dust
Source: Annual Congress 2009 - High molecular sensitisers and biological dusts
Year: 2009
Evaluating the utility of urinary metal concentrations as biomarkers of air pollutant exposures.
Source: International Congress 2017 – Air pollution
Year: 2017
Microbial volatile organic compounds (MVOC) and plasticizers in schools in relation to asthma and respiratory symptoms among pupils
Source: Eur Respir J 2006; 28: Suppl. 50, 698s
Year: 2006
Increased blood lead and cadmium levels in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 413s
Year: 2001
Effect of grain dust exposure on pulmonary gas exchange and serum pneumoprotein levels
Source: Annual Congress 2010 - Organic dust, allergen exposure and respiratory disease
Year: 2010
Assessment of induced sputum cellularity in COPD patients belonging to two different classes of air pollution exposure.
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Diet and alcohol affect exhaled volatile organic compounds (VOCs)
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Low levels of air pollution induce changes of lung function in a panel of schoolchildren
Source: Eur Respir J 2006; 27: 1138-1143
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept